We congratulate Catherine Arundel and colleagues on the publication of the SWHSI-2 trial and report that 686 patients out of 1,895 screened(s) were successfully recruited into the trial, which the authors consider an exemplary success regardless of the circumstances. The authors also emphasize that recruitment and completion of the study were achieved despite profound disruptions to the National Health Service caused by the COVID-19 pandemic. The correspondence acknowledges the efforts of the team and collaborators as evidence of the UK's continued commitment to evidence-based medicine. The text also states that the successful recruitment is a testament to the resilience of the UK's clinical research infrastructure. Following the SWHSI-2 study, the authors suggest that diabetic foot wound healing is not a one-size-fits-all solution for all patients.